NCT04957628 AlcoTail - Implementation of Tailored Interventions
| NCT ID | NCT04957628 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Oslo University Hospital |
| Condition | Alcohol Consumption |
| Study Type | OBSERVATIONAL |
| Enrollment | 4,200 participants |
| Start Date | 2021-09-13 |
| Primary Completion | 2026-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 4,200 participants in total. It began in 2021-09-13 with a primary completion date of 2026-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study aims to investigate the implementation and real-world effects of an intervention for harmful use of alcohol and psychoactive medicinal drugs among hospital inpatients. Due to the negative impact of alcohol consumption on health outcomes, a call for action has been made by the Norwegian Ministry of Health, with focus on screening patients for alcohol consumption and evidence-based tailored interventions for those with medium or high consumption. In addition, non-prescribed use of psychoactive medicinal drugs, or concomitant use with alcohol, can also have negative health effects, therefore improved monitoring of the use of these are warranted. Interventions will be introduced as routine procedures at Norwegian hospitals in the upcoming year, and 2500 patients receiving acute medical care will be included in the control group before the intervention is implemented, and 2500 patients in the case group after the implementation is effectuated. This study will evaluate the implementation process using baseline data on self-reported alcohol- and psychoactive medicine use, motivation to reduce consumption and mental distress. In addition, left-over blood samples used for diagnostic purposes will be collected and analyzed for alcohol, psychoactive medicinal and illicit drugs. After 12 months baseline data will be coupled to patient journal data and relevant registry data in order to evaluate the effects of the intervention.
Eligibility Criteria
Inclusion Criteria: * Patients admitted to Medical wards Exclusion Criteria: * Inability to understand written and verbal Norwegian * Cognitive or mental inability to consent to participation * Injury or planned surgery as primary reason for admission
Contact & Investigator
Frequently Asked Questions
Who can join the NCT04957628 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Alcohol Consumption. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04957628 currently recruiting?
Yes, NCT04957628 is actively recruiting participants. Contact the research team at anners.lerdal@medisin.uio.no for enrollment information.
Where is the NCT04957628 trial being conducted?
This trial is being conducted at Oslo, Norway.
Who is sponsoring the NCT04957628 clinical trial?
NCT04957628 is sponsored by Oslo University Hospital. The trial plans to enroll 4,200 participants.